IL18 and graft versus host disease: Clinical appearance and examination of weight curves revealed that IL-18 treated mice had more significant manifestations of GVHD as indicated by lethargy, hunched posture, generalized erythema, and a progressive reduction in mean weights from pretransplant levels (data not shown).